Tillkännagivande • Apr 29
Trupanion, Inc., Annual General Meeting, Jun 10, 2026 Trupanion, Inc., Annual General Meeting, Jun 10, 2026. Location: 6100 4th avenue south, washington 98108., seattle United States Tillkännagivande • Apr 17
Trupanion, Inc. to Report Q1, 2026 Results on Apr 30, 2026 Trupanion, Inc. announced that they will report Q1, 2026 results After-Market on Apr 30, 2026 Tillkännagivande • Feb 13
Trupanion, Inc. Reports Goodwill Impairment Charges for the Fourth Quarter Ended December 31, 2025 Trupanion, Inc. reported goodwill impairment charges for the fourth quarter ended December 31, 2025. The company's goodwill impairment charges were $1,129,000 against $5,299,000 a year ago. Tillkännagivande • Jan 23
Trupanion, Inc. to Report Q4, 2025 Results on Feb 12, 2026 Trupanion, Inc. announced that they will report Q4, 2025 results After-Market on Feb 12, 2026 Tillkännagivande • Oct 31
Trupanion, Inc. Appoints Bradley Powell to Board of Directors Trupanion, Inc. announced the appointment of Bradley Powell, former Chief Financial Officer of Expeditors International of Washington, to the Company’s Board of Directors. Mr. Powell served as Chief Financial Officer at Expeditors International of Washington, Inc., from October 2008 to September 2025. Prior to joining Expeditors, Mr. Powell served as Chief Financial Officer of Eden Bioscience Corporation, a publicly traded biotechnology company, from July 1998 to September 2008, during which time he led the company through a successful initial public offering in 2000. Mr. Powell holds a BS in Accounting from Central Washington University. Tillkännagivande • Oct 22
Trupanion, Inc. to Report Q3, 2025 Results on Nov 06, 2025 Trupanion, Inc. announced that they will report Q3, 2025 results After-Market on Nov 06, 2025 Tillkännagivande • Jul 18
Trupanion, Inc. to Report Q2, 2025 Results on Aug 07, 2025 Trupanion, Inc. announced that they will report Q2, 2025 results After-Market on Aug 07, 2025 Tillkännagivande • May 01
Trupanion, Inc., Annual General Meeting, Jun 11, 2025 Trupanion, Inc., Annual General Meeting, Jun 11, 2025. Location: at 6100 4th avenue south, washington 98108, seattle, United States Tillkännagivande • Apr 18
Trupanion, Inc. to Report Q1, 2025 Results on May 01, 2025 Trupanion, Inc. announced that they will report Q1, 2025 results After-Market on May 01, 2025 Tillkännagivande • Feb 22
Trupanion, Inc. Reports Unaudited Impairment Results for the Fourth Quarter Ended December 31, 2024 Trupanion, Inc. reported unaudited impairment results for the fourth quarter ended December 31, 2024. For the quarter, the company reported Goodwill impairment charges was $5,299,000. Tillkännagivande • Jan 23
Trupanion, Inc. to Report Q4, 2024 Results on Feb 19, 2025 Trupanion, Inc. announced that they will report Q4, 2024 results After-Market on Feb 19, 2025 Tillkännagivande • Oct 15
Trupanion, Inc. to Report Q3, 2024 Results on Oct 30, 2024 Trupanion, Inc. announced that they will report Q3, 2024 results After-Market on Oct 30, 2024 Breakeven Date Change • Aug 26
Forecast to breakeven in 2025 The 8 analysts covering Trupanion expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 69% to 2024. The company is expected to make a profit of US$771.3k in 2025. Average annual earnings growth of 72% is required to achieve expected profit on schedule. Tillkännagivande • Jul 19
Trupanion, Inc. to Report Q2, 2024 Results on Aug 08, 2024 Trupanion, Inc. announced that they will report Q2, 2024 results at 4:00 PM, US Eastern Standard Time on Aug 08, 2024 Tillkännagivande • May 03
Trupanion, Inc. Announces Chief Executive Officer Changes Trupanion, Inc. announced that its Board of Directors has unanimously approved the appointment of Margi Tooth to Chief Executive Officer, effective August 1, 2024. Tooth’s appointment to CEO marks the culmination of a multi-year, board-led process. Tooth will also continue as President and hold the dual titles of CEO and President. Additionally, Tooth is anticipated to be appointed to Trupanion’s Board of Directors during its July meeting. Trupanion’s founder and outgoing CEO Darryl Rawlings will continue to serve in the role of Chair of the Board, in which capacity he will continue to oversee the Company’s board of directors. Tooth holds nearly two decades of experience as a growth-oriented leader within the pet insurance category. Her tenure includes over seven years with the UK’s larger pet insurance provider, during which time the category saw tremendous growth, reaching approximately 25% penetration. Tooth’s appointment to CEO follows a proven career at Trupanion, spanning over a decade in leadership positions of increasing responsibility including Chief Marketing Officer, Chief Revenue Officer and as of January of 2021, President. During her time at Trupanion, Tooth has played a pivotal role in the company's growth and success, overseeing the execution of its strategic plan which includes diversifying into new channels, products, and geographies, while ensuring that the core Trupanion product, designed with the heart of the veterinary community in mind, remains front and center. Under her leadership, Trupanion has achieved significant milestones, including surpassing $1 billion in revenue, reaching over 1 million subscription pets, and paying out nearly $3 billion in veterinary invoices. Additionally, Tooth's leadership has led to improving operational efficiency through targeted overhauls in several departments. Ms. Tooth's extensive experience, including serving as President of Trupanion since 2021, coupled with her deep understanding of the pet insurance industry, strongly positions her to lead Trupanion into its next phase of growth in its global underpenetrated markets, while staying aligned with the needs of veterinarians and pet owners. Rawlings once again confirmed his commitment to serve as Chair of the Board until 2035, if amenable to shareholders. In addition to serving as Chair of the Board, Rawlings will enter into a consulting agreement with Trupanion to provide services related to the development of the Company’s food initiative. Tillkännagivande • Apr 24
Trupanion Introduces truInsights: A Pet Health Data Initiative Trupanion announced the launch of truInsights, an initiative designed to deliver valuable health-related data and insights to pet parents. This initiative will provide a series of discussions covering topics relevant to everyday pet health, offering data-driven insights and practical advice to pet parents. Trupanion’s years of pet health data and deep connections across the veterinary space enable an abundance of ‘truInsights’ to illuminate everyday pet health considerations. Pet parents, veterinarians, and all those invested in pet well-being can anticipate a series of engaging resources from truInsights, including informative releases, podcasts and more, all aimed at promoting a deeper understanding of pet health and fostering a stronger bond between pets and their caregivers. Tillkännagivande • Apr 21
Trupanion, Inc. to Report Q1, 2024 Results on May 02, 2024 Trupanion, Inc. announced that they will report Q1, 2024 results After-Market on May 02, 2024 Tillkännagivande • Apr 05
Daniel “Dan” Levitan and Zay Satchu, Members of the Board of Directors Will Not Stand for Re-Election of Trupanion, Inc On April 2, 2024, Daniel “Dan” Levitan and Dr. Zay Satchu, each a member of the Board of Directors (the “Board”) of Trupanion, Inc. (“ Trupanion ”), notified Trupanion that they will not stand for re-election at the upcoming Annual Stockholders’ Meeting to be held in June 2024 (“ 2024 Annual Meeting ”). Neither Mr. Levitan’s nor Dr. Satchu’s decision not to stand for re-election was a result of any disagreement with Trupanion or the Board. Each of Mr. Levitan and Dr. Satchu have indicated their intention to continue to serve as a director of Trupanion until the 2024 Annual Meeting. Tillkännagivande • Feb 09
Trupanion, Inc. to Report Q4, 2023 Results on Feb 15, 2024 Trupanion, Inc. announced that they will report Q4, 2023 results After-Market on Feb 15, 2024 Tillkännagivande • Nov 09
Trupanion, Inc. Appoints Richard Enthoven as an Independent Director Trupanion, Inc. has appointed Richard Enthoven, Director at PetSure Australia and Hollard Holdings Australia, as an independent director to the Company’s Board of Directors, effective November 7, 2023. Richard Enthoven, 53, serves on the Board of Directors of PetSure in Australia, where he previously served as Chair until December 2022. He is also involved with the Hollard Insurance Group in Australia, leading it as CEO until 2021 and currently serving as a Non-Executive Director. He is also the Chairman of Greenstone, Australia's leading direct life insurance operation. Mr. Enthoven holds an MSc degree from the London School of Economics and a B. A from the University of Southern California. Mr. Enthoven was chosen to serve on the Board based on his significant industry experience, track record growing global businesses, and strategic alignment. Since January of 2023, Trupanion has added four independent directors to its Board. Tillkännagivande • Oct 18
Trupanion, Inc. to Report Q3, 2023 Results on Nov 02, 2023 Trupanion, Inc. announced that they will report Q3, 2023 results After-Market on Nov 02, 2023 Tillkännagivande • Sep 07
Trupanion, Inc. Announces Appointment of Fawwad Qureshi as Chief Financial Officer on September 25, 2023 Trupanion, Inc. announced the appointment of Fawwad Qureshi as Chief Finance Officer. Mr. Qureshi will officially join Trupanion on September 25, 2023. Mr. Qureshi joins Trupanion with over 20 years of senior-level financial experience, successfully steering growth in revenue and profitability for publicly-traded, global growth companies. Notably, during his most recent tenure at Expedia Group as Senior Vice President of Finance and CFO of Brands, Qureshi had full P&L and commercial responsibility for its over $9 billion portfolio of world-class consumer brands including Expedia, Vrbo, Hotels.com, Orbitz and Travelocity. Prior to Expedia, Qureshi acted as the CFO for Nike Global Technology, where he managed its omni-channel portfolio of technology investments, covering digital product development for consumer-facing, e-commerce properties. Prior to that, he worked at Intel in finance positions of increasing seniority. Mr. Qureshi holds a Master of Business Administration from Boston University and a Bachelor of Arts from St. Olaf College. Wei Li, who has acted as interim CFO since June, will remain with Trupanion in the capacity of SVP, Finance and Corporate Controller. Tillkännagivande • Jul 14
Trupanion, Inc. to Report Q2, 2023 Results on Aug 03, 2023 Trupanion, Inc. announced that they will report Q2, 2023 results After-Market on Aug 03, 2023 Tillkännagivande • Jul 06
Trupanion, Inc. Announces Appointment of Max Brodn as Independent Director Trupanion, Inc. announced that Max Brodn, Chief Financial Officer of Aflac Incorporated, has been appointed to serve as an independent director effective July 4, 2023. This appointment expands the Board to nine directors, eight of whom are independent. With over 17 years of experience and leadership managing global financial and insurance portfolios, Mr. Brodn is currently the Executive Vice President and Chief Financial Officer of Aflac Incorporated where he has served in various leadership roles of ascending responsibility since April 2017. Before joining Aflac Incorporated, Mr. Brodn served as senior portfolio manager at Norges Bank from 2007 to 2017, managing an equity portfolio of global financial and insurance stocks. Mr. Brodn holds a Master of Science in both accounting and finance from Stockholm School of Economics. Tillkännagivande • Feb 18
Trupanion, Inc. Provides Earnings Guidance for the First Quarter and Full Year of 2023 Trupanion, Inc. provided earnings guidance for the first quarter and full year of 2023. As for the first quarter, total revenue is expected to be in the range of $249 million to $253 million. revenue is expected to be in the range of $164 million to $165 million. This is 18% year-over-year growth at the midpoint. For the full year of 2023, the company are now planning to grow revenue in the range of $1.32 billion to $1.64 billion. This is approximately 16% growth at the midpoint. The company are planning to grow subscription revenue in the range of $700 million to $720 million, representing 19% year-over-year growth at the midpoint. Board Change • Jan 31
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. 4 highly experienced directors. Independent Director Jackie Davidson was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Tillkännagivande • Jan 26
Trupanion, Inc. to Report Q4, 2022 Results on Feb 15, 2023 Trupanion, Inc. announced that they will report Q4, 2022 results at 4:00 PM, US Eastern Standard Time on Feb 15, 2023 Recent Insider Transactions • Aug 27
Insider recently sold Mex$4.3m worth of stock On the 24th of August, Gavin Friedman sold around 3k shares on-market at roughly Mex$1,437 per share. In the last 3 months, there was an even bigger sale from another insider worth Mex$10m. Insiders have been net sellers, collectively disposing of Mex$29m more than they bought in the last 12 months. Board Change • Aug 16
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. 5 highly experienced directors. Independent Director Jackie Davidson was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. 
